Conformational properties of serine proteinase inhibitors (serpins) confer multiple pathophysiological roles

被引:158
作者
Janciauskiene, S [1 ]
机构
[1] Malmo Univ Hosp, Ing 46, Wallenberg Lab, Dept Med, S-20502 Malmo, Sweden
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2001年 / 1535卷 / 03期
关键词
serpin; conformational polymorphism; alpha(1)-antitrypsin; alpha(1)-antichymotrypsin;
D O I
10.1016/S0925-4439(01)00025-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Serine proteinase inhibitors (Serpins) are irreversible suicide inhibitors of proteases that regulate diverse physiological processes such as coagulation, fibrinolysis, complement activation, angiogenesis, apoptosis, inflammation, neoplasia and viral pathogenesis. The molecular structure and physical properties of serpins permit these proteins to adopt a number of variant conformations under physiological conditions including the native inhibitory form and several inactive, noninhibitory forms, such as complexes with protease or other ligands, cleaved, polymerised and oxidised. Alterations of a serpin which affect its structure and/or secretion and thus reduce its functional levels may result in pathology. Serpin dysfunction has been implicated in thrombosis, emphysema, liver cirrhosis, immune hypersensitivity and mental disorders. The loss of inhibitory activity of serpins necessarily results in an imbalance between proteases and their inhibitors, but it may also have other physiological effects through the generation of abnormal concentrations of modified, non-inhibitory forms of serpins. Although these forms of inhibitory serpins are detected in tissues and fluids recovered from inflammatory sites, the important questions of which conditions result in generation of different molecular forms of serpins, what biological function these forms have, and which of them are directly linked to pathologies and/or may be useful markers for characterisation of disease states, remain to be answered. Elucidation of the biological activities of non-inhibitory forms of serpins may provide useful insights into the pathogenesis of diseases and suggest new therapeutic strategies. (C) 2001 Published by Elsevier Science B.V.
引用
收藏
页码:221 / 235
页数:15
相关论文
共 151 条
[1]  
ABRAHAM CR, 1991, ANN NY ACAD SCI, V640, P161
[2]   ALPHA-1-ANTICHYMOTRYPSIN IS ASSOCIATED SOLELY WITH AMYLOID DEPOSITS CONTAINING THE BETA-PROTEIN - AMYLOID AND CELL LOCALIZATION OF ALPHA-1-ANTICHYMOTRYPSIN [J].
ABRAHAM, CR ;
SHIRAHAMA, T ;
POTTER, H .
NEUROBIOLOGY OF AGING, 1990, 11 (02) :123-129
[3]   THE PROTEASE INHIBITOR, ALPHA-1-ANTICHYMOTRYPSIN, IS A COMPONENT OF THE BRAIN AMYLOID DEPOSITS IN NORMAL AGING AND ALZHEIMERS-DISEASE [J].
ABRAHAM, CR ;
POTTER, H .
ANNALS OF MEDICINE, 1989, 21 (02) :77-81
[4]   THE ASSESSMENT OF ALPHA-1-PROTEINASE INHIBITOR FORM AND FUNCTION IN LUNG LAVAGE FLUID FROM HEALTHY-SUBJECTS [J].
AFFORD, SC ;
BURNETT, D ;
CAMPBELL, EJ ;
CURY, JD ;
STOCKLEY, RA .
BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1988, 369 (09) :1065-1074
[5]  
BANDA MJ, 1988, J BIOL CHEM, V263, P4481
[6]   MOLECULAR EVOLUTION OF SERPINS - HOMOLOGOUS STRUCTURE OF THE HUMAN ALPHA-1-ANTICHYMOTRYPSIN AND ALPHA-1-ANTITRYPSIN GENES [J].
BAO, JJ ;
SIFERS, RN ;
KIDD, VJ ;
LEDLEY, FD ;
WOO, SLC .
BIOCHEMISTRY, 1987, 26 (24) :7755-7759
[7]   SYNTHESIS OF ALPHA-1-ANTICHYMOTRYPSIN AND ALPHA-1-ANTITRYPSIN BY HUMAN TROPHOBLAST [J].
BERGMAN, D ;
KADNER, SS ;
CRUZ, MR ;
ESTERMAN, AL ;
TAHERY, MM ;
YOUNG, BK ;
FINLAY, TH .
PEDIATRIC RESEARCH, 1993, 34 (03) :312-317
[8]  
Beyeler C, 2000, J RHEUMATOL, V27, P15
[9]  
Bird P I, 1998, Results Probl Cell Differ, V24, P63
[10]   Local control of α1-proteinase inhibitor levels:: regulation of α1-proteinase inhibitor in the human cornea by growth factors and cytokines [J].
Boskovic, G ;
Twining, SS .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1998, 1403 (01) :37-46